PIM_Invokana_Jardiance

active
URL
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1078.695
Version
20231020
PublisherOptum StewardDate2023-10-20T01:04:05-04:00Purpose

(Clinical Focus: Medications containing single ingredient of Dapagliflozin (Invokana) and Empagliflozin (Jardiance) in different strengths),(Data Element Scope: DRUG_CLASS_MEMBERS: PHARMACOLOGIC),(Inclusion Criteria: Only single ingredient of Dapagliflozin (Invokana) and Empagliflozin (Jardiance)),(Exclusion Criteria: Combination drugs)

Expansion
<<>>>
CodeDisplaySystem
1151133http://www.nlm.nih.gov/research/umls/rxnorm
1373464http://www.nlm.nih.gov/research/umls/rxnorm
1373467http://www.nlm.nih.gov/research/umls/rxnorm
1373469http://www.nlm.nih.gov/research/umls/rxnorm
1373466http://www.nlm.nih.gov/research/umls/rxnorm
1373463http://www.nlm.nih.gov/research/umls/rxnorm
1373462http://www.nlm.nih.gov/research/umls/rxnorm
1373458http://www.nlm.nih.gov/research/umls/rxnorm
1373473http://www.nlm.nih.gov/research/umls/rxnorm
1373465http://www.nlm.nih.gov/research/umls/rxnorm
317541http://www.nlm.nih.gov/research/umls/rxnorm
1373471http://www.nlm.nih.gov/research/umls/rxnorm
1151131http://www.nlm.nih.gov/research/umls/rxnorm
1373468http://www.nlm.nih.gov/research/umls/rxnorm
1373472http://www.nlm.nih.gov/research/umls/rxnorm
1373470http://www.nlm.nih.gov/research/umls/rxnorm
1373459http://www.nlm.nih.gov/research/umls/rxnorm
1373461http://www.nlm.nih.gov/research/umls/rxnorm
1373460http://www.nlm.nih.gov/research/umls/rxnorm
1151133http://www.nlm.nih.gov/research/umls/rxnorm